US2018360830A1PendingUtilityA1

Compounds, compositions and methods of agelastatin alkaloids

Assignee: MASSACHUSETTS INST TECHNOLOGYPriority: Sep 19, 2013Filed: Apr 12, 2018Published: Dec 20, 2018
Est. expirySep 19, 2033(~7.1 yrs left)· nominal 20-yr term from priority
A61K 31/4985C07D 487/14A61P 35/02A61K 31/498
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention, among other things, provides compounds, compositions and methods for treatment of cancer. In some embodiments, the present invention provides methods for treating blood cancer using agelastatin alkaloids.

Claims

exact text as granted — not AI-modified
1 . A method for treating blood cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof, wherein:
 R 1  is —H or —CH 3 ; 
 R 2  is —OH or —OCH 3 ; 
 R 3  is —H or —OH; and 
 R 4  is —H, or —Br when R 1  is —CH 3 .

Join the waitlist — get patent alerts

Track US2018360830A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.